Drug−herb interaction through inhibition of cytochrome P450 alters the pharmacological response and/or toxicities of drug used concomitantly. In our screening, Piper nigrum L. was observed to inhibit cytochrome P450 2D6 (CYP2D6) in human liver microsomes. Thus, the MeOH extract of this plant was investigated for their chemical constituents and 19 alkamides including a new pipercyclobutanamide were isolated. Their structures were elucidated on the basis of spectroscopic analyses. The isolated compounds were tested for their inhibition on human liver microsomal dextromethorphan O-demethylation activity, a selective marker for CYP2D6, and pipercyclobutanamide A (17) showed the most potent inhibition with an IC 50 value of 0.34 µM. The result demonstrated the potential of drug−alkamides interaction on concomitant consume of white pepper with the drugs being metabolized by CYP2D6.
Liver is the major organ responsible for the biotransformation of drugs or other xenobiotics. The smooth endoplasmic reticulum (subcellular membrane system) in hepatic tissue is rich in enzymes for metabolism, known as cytochromes P450 (CYP) [1] . This superfamily is subdivided into families and subfamilies that are defined solely on the basis of amino acid sequence homology. The CYP1, 2, and 3 families encode the enzyme involved in the majority of all drug biotransformation, while the gene products of the remaining CYP families are important in the metabolism of endogenous compounds such as steroids and fatty acids [2] . Approximately 70% of human liver CYP is accounted for by CYP1A2, CYP2A6, CYPB6, CYP2C, CYP2D6, CYP2E1, and CYP3A4 enzymes [3] .
CYP2D6 is a polymorphic enzyme and the functional form is absent in 5 to 9% of Caucasians as a result of autosomal recessive inheritance of gene mutations [4] . It represents less than 5% of total CYP protein and metabolizes more than 30% of the clinically used drugs, including antidepressant, antipsychotic, and cardiovascular drugs [5] . Inhibition of CYP leads to higher plasma concentrations of drugs, which are used concomitantly and metabolized by the enzyme, to result in the increase of the toxicity or in the alteration of their efficacy levels. A variety of components in numerous species of plants have been reported to inhibit multiple forms of CYP [6, 7] . Some examples include bergamotin, a component of grapefruit juice, capsaicin from chili peppers, and diallylsulfide found in garlic oil [8] [9] [10] . We also reported sesquiterpenes and flavonol glycosides of Zingiber aromaticum, lignans of Piper cubeba, and alkaloids of Chataranthus roseus for their CYP inhibitory activity [11] [12] [13] .
In our previous study, we observed that the methanol extract of Piper nigrum L. (Piperaceae) strongly inhibited human liver microsomal dextromethrophan O-demethylation by CYP2D6 [14] . P. nigrum is the most popular spice in the world and has received much attention due to its many pharmacological activities [15] . In Indonesia, P. nigrum has been used as traditional medicine for treatment of hypertension, digestive disorder, dyspnea, and diaphoresis [16] . A number of steroids, terpenes, lignans, flavones, and alkaloids/amides are known to occur in this plant [17] and CYP3A4 inhibitory constituents were reported [18] [19] [20] . On the CYP2D6 inhibitory constituents, however, there is no report, and thus we have carried out the phytochemical investigation of its MeOH extract and isolated 19 alkamides including a new pipercyclobutanamide (19) . In this paper, we report the isolation and structure determination of the new compound, pipercyclobutanamide C (19) , together with the CYP2D6 inhibitory activity of the isolated compounds.
NPC Natural Product Communications
P. nigrum fruit was extracted with MeOH and the MeOH extract was chromatographed on silica gel with a n-hexane−EtOAc solvent system to give nine fractions. The fractions were further separated by repeated column chromatography, followed by normal-and reversed-phase preparative TLC, to afford 19 alkamides (1−19) including a new pipercyclobutanamide (19) (Figure 1 ). Their structures were confirmed by comparisons of their spectral data with those in literatures to be Ncinnamoylpiperidine (1) [21] , (2E,4E)-Nisobutyldecadienamide (2) [22] , (2E)-octadec-2-enoic acid piperidide (3) [23] , feruperine (4) [24] , pipernonalin (5) [25] , piperamide-A6:2(2E,6E) (6) [26] , piperanine (7) [27] , piperine (8) [28] , dehydropipernonaline (9) [29] , piperolein B (10) [28] , piperolein A (11) [30] , pipercide (12) [31] , piperylin (13) [28] , piperamide-C9:3(2E,4E,8E) (14) [28] , piperamide-C9:1(8E) (15) [28] , piperamide-C7:1(6E) (16) [28] , pipercyclobutanamide A (17) [32] , and nigramide R (18) [17] .
Pipercyclobutanamide C (19) was isolated as colorless amorphous solid with [α] D 24 0° (c 0.15, CHCl 3 ). Its IR spectrum showed absorption bands corresponding to carbonyl (1630 cm -1 ) and methylenedioxyphenyl (930 cm -1 ) groups. The EI-MS showed the molecular ion peak at m/z 622 and the molecular formula C 38 H 42 N 2 O 6 was established by HR-EI-MS. In the NMR spectra, however, the signals ascribable to only 21 hydrogens and 19 carbons were observed. This and an intense fragment ion at m/z 311 in EI-MS suggested the symmetrical nature of 19.
The 1 H and 13 C NMR data revealed the presence of a methylenedioxyphenyl group, two trans-olefins, a piperidine ring, and a carbonyl group. The COSY spectrum showed correlations assignable to -C (2) methylenedioxyphenyl group, while the correlations of both H-5 and H-4 with C-3 and of H-2 with C-1 indicated the connection between the conjugated double bonds and the carbonyl carbon through the two methines, which led to the half unit of the molecule. The correlation of both H-2' and H-6' with C-1 also confirmed the piperidine ring to be bonded to the carbonyl carbon to form an amide linkage ( Figure 2 ). Thus, 19 should be a symmetrical cyclobutanamide. Figure 4 ). In addition, the coupling pattern of H-2 and H-3 was more similar to that of a known compound 18 with a type d configuration [17] than dipiperamide B with a type c configuration [18] . Finally, 19 was concluded to contain the cyclobutane ring with a head-to-head structure, i.e., type d, based on the coupling constant of H-2 (H-2'') and H-3 (H-3'') (J 2,3 = 6.3 Hz, J Since 17, 18, and 19 are optically inactive, an enzymatic cyclization may not be involved in their biosynthesis. These pipercyclobutanamide are presumably generated by [2π+2π] cycloadditions of piperine or other constituents of this plant during the process of producing white pepper [18] . This was supported by the reports that dipiperamide A isolated from P. nigrum can be synthesized from a solid state photodimerization of an (E)-cinnamic acid derivatives and piplartine-dimer A was generated by irradiation of piplartine with sunlight in P. tuberculatum [35, 36] .
The isolated compounds were tested for their CYP2D6 inhibitory activity (Table 1) . Among them, 17 showed the most potent inhibitory activity with an IC 50 value of 0.34 µM, while 2, 6, 9, and 15 showed moderate in their inhibition, and compounds 1, 3, 4, 11, 12, 18, and 19 inhibited CYP2D6 only weakly. The presence of methylenedioxyphenyl ring and nitrogen atom is reported to be important for their inhibition on CYP2D6 [3, 37] . Methylenedioxyphenyl group is metabolized to result in the generation of carbene intermediates which can form a strong covalent complex with iron center of the heme in cytochromes [37] . Many of the potent CYP inhibitors are nitrogen-containing drugs, such as imidazole, pyridines, and quinolines, which can inhibit CYP with bind to the prosthetic heme iron or to the lipophilic region of the protein [3] . Thus, inhibition of CYP2D6 by constituents of P. nigrum could also be due to the presence of the piperidine, pyrrolidine, or isobutylamide group and/or the methylenedioxyphenyl group. The MeOH extract (8.1 g) was subjected to silica gel column chromatography with a n-hexane-EtOAc solvent system to yield 9 fractions: fraction 1 (388 mg), n-hexane-10% EtOAc elute; fraction 2 (359 mg), n-hexane-20% EtOAc elute; fraction 3 (229 mg), n-hexane-30% EtOAc elute; fraction 4 (1.4 g), n-hexane-40% EtOAc elute; fraction 5 (3.2 g), n-hexane-60% EtOAc elute; fraction 6 (650 mg), n-hexane-80% EtOAc elute; fraction 7 (576 mg), EtOAc elute; fraction 8 (486 mg), EtOAc-20% MeOH elute; and fraction 9 (572 mg), MeOH elute. ). 13 [38] . Briefly, in disposable culture tubes (13 × 100 mm; Iwaki, Tokyo, Japan) containing phosphate buffer (pH 7.4), [O-methyl- 14 C]dextromethorphan (0.1 µCi/incubation; 100 µM in 5% of MeOH), and 50 µl of HLM (4 mg/ml) were added to varying concentrations of test specimens in 500 µl of total incubation volume. After a preincubation period of 5 min in shaking water bath at 37 °C. The reaction is initiated by adding 50 µl of NADPH-generating system (4.20 mg/ml of NADP + in a solution of 100 mM G-6-P, MgCl 2 , and 10 U/ml G-6-P dehydrogenase), and the incubation was continued for 20 min (CYP2D6) in a shaking water bath at 37 °C. The reaction was stopped by adding of 125 µl of 10% trichloroacetic acid (Nacalai Tesque, Inc., Kyoto, Japan), and the solution was centrifuged at 3000 rpm for 10 min at room temperature. The supernatant was applied to Envi-Carb solid-phase extraction columns (Supelco, UK) and was eluted with two volumes of ultrapure water (2 × 500 µl).
After adding 10 ml of Clear-sol I (Nacalai Tesque, Inc., Kyoto, Japan), the eluted radioactivity was quantified by liquid scintillation counting LS 6500 (Beckman, USA). Quinidine sulfate dihydrate (Wako Pure Chemicals Industry, Ltd., Osaka, Japan) was used as a positive control, while MeOH was used as a negative control. Correction was made for radioactivity eluted from control incubation in which HLM and NADPH-generating systems had been omitted. The assays were performed in duplicate for all test specimens, and remaining activity was analyzed using software product WinNonlin Ver.3.1 (Pharsight Corporation, Mountain View, CA. USA). IC 50 values (concentration of test specimen causing 50% reduction in activity relative to the negative control) were calculated by linear regression analysis of the log test specimen concentration versus percentage control activity plots.
